Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.
复制标题
DOI:
10.1084/jem.20132620
复制
发表时间:
2014-09-22
期刊:
影响因子:
--
通讯作者:
Colonna M
中科院分区:
文献类型:
--
作者:
Rowland SL;Riggs JM;Gilfillan S;Bugatti M;Vermi W;Kolbeck R;Unanue ER;Sanjuan MA;Colonna M
Transient, genetic elimination of a specialized group of cells called plasmacytoid dendritic cells (pDCs) reverses many features of lupus in mice. Disease reduction was attributed in part to decreased expression of inflammatory molecules called interferons, which are produced primarily by pDCs. Plasmacytoid dendritic cells (pDCs) have long been implicated in the pathogenesis of lupus. However, this conclusion has been largely based on a correlative link between the copious production of IFN-α/β by pDCs and the IFN-α/β “signature” often seen in human lupus patients. The specific contribution of pDCs to disease in vivo has not been investigated in detail. For this reason, we generated a strain of BXSB lupus-prone mice in which pDCs can be selectively depleted in vivo. Early, transient ablation of pDCs before disease initiation resulted in reduced splenomegaly and lymphadenopathy, impaired expansion and activation of T and B cells, reduced antibodies against nuclear autoantigens and improved kidney pathology. Amelioration of pathology coincided with decreased transcription of IFN-α/β–induced genes in tissues. PDC depletion had an immediate impact on the activation of immune cells, and importantly, the beneficial effects on pathology were sustained even though pDCs later recovered, indicating an early pDC contribution to disease. Together, our findings demonstrate a critical function for pDCs during the IFN-α/β–dependent initiation of autoimmune lupus and point to pDCs as an attractive therapeutic target for the treatment of SLE.
登录
查看更多内容
影响因子:
12.8
作者:
Goules, Andreas;Tzioufas, Athanasios G.;Routsias, John G.
通讯作者:
Routsias, John G.
影响因子:
20.3
作者:
Hao, Yi;O'Neill, Patrick;Cancro, Michael P.
通讯作者:
Cancro, Michael P.
DOI:
10.4049/jimmunol.1201477
发表时间:
2012-12-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Baccala R;Gonzalez-Quintial R;Schreiber RD;Lawson BR;Kono DH;Theofilopoulos AN
通讯作者:
Theofilopoulos AN
DOI:
10.1084/jem.20021553
发表时间:
2003-03-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bennett L;Palucka AK;Arce E;Cantrell V;Borvak J;Banchereau J;Pascual V
通讯作者:
Pascual V
DOI:
10.1038/nri3383
发表时间:
2013-02
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--